Home/Filings/4/0001144204-18-020005
4//SEC Filing

LOSORDO DOUGLAS W 4

Accession 0001144204-18-020005

CIK 0000320017other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 7:00 PM ET

Size

6.1 KB

Accession

0001144204-18-020005

Insider Transaction Report

Form 4
Period: 2018-04-06
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
  • Award

    Performance Rights

    2018-04-06+13,30013,300 total
    Common Stock (13,300 underlying)
Footnotes (2)
  • [F1]Each performance right represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]The performance criteria was satisfied on April 6, 2018 and the performance right shall vest in full on the date of stockholder approval of a new or amended equity plan provided that such approval is obtained on or prior to August 30, 2018 and if not obtained by such date this performance right shall terminate (the "Vesting Date").

Issuer

CALADRIUS BIOSCIENCES, INC.

CIK 0000320017

Entity typeother

Related Parties

1
  • filerCIK 0001583810

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 7:00 PM ET
Size
6.1 KB